Mandate

Vinge advises Eleda in connection with acquisition of JVAB

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Järfälla VA- & Byggentreprenad AB (“JVAB”).

JVAB is focusing on civil engineering and transmission infrastructure in the Stockholm region. JVAB has around 150 employees and sales of approximately SEK 0.7 billion in 2019. The majority of JVAB is owned by the founding family, who will reinvest a significant portion in the combined Group. JVAB strengthens Eleda’s geographical coverage in the Stockholm area and has strong expertise in water works. The acquisition is carried out in connection with Altor Fund V’s acquisition of a majority stake in Eleda and Eleda’s acquisition of ONE Nordic.

Vinge’s team consisted of partner Christina Kokko together with associates Michaela Cronemyr, Manne Bergström, Hanna Risberg and Fredric Reissmüller (M&A), Trine Osen Bergqvist, Xandra Ståhlberg and Lisa Malmborg (Competition), Lisa Ullman (Employment), Rebecka Maltenius (Construction) and Nathalie Hughes (VDR assistant).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025